Low total lymphocyte count is associated with poor survival in patients with resected pancreatic adenocarcinoma receiving a GM-CSF secreting pancreatic tumor vaccine.

Low total lymphocyte count is associated with poor survival in patients with resected pancreatic adenocarcinoma receiving a GM-CSF secreting pancreatic tumor vaccine. Ann Surg Oncol. 2013 Dec; 20 Suppl 3:S725-30.

View in: PubMed

subject areas

Adjuvants, Immunologic
Adjuvants, Immunologic
Adult
Adult
Aged
Aged
Aged, 80 and over
Aged, 80 and over
Antimetabolites, Antineoplastic
Antimetabolites, Antineoplastic
Cancer Vaccines
Cancer Vaccines
Carcinoma, Pancreatic Ductal
Carcinoma, Pancreatic Ductal
Clinical Trials, Phase II as Topic
Clinical Trials, Phase II as Topic
Combined Modality Therapy
Combined Modality Therapy
Female
Female
Fluorouracil
Fluorouracil
Follow-Up Studies
Follow-Up Studies
Granulocyte-Macrophage Colony-Stimulating Factor
Granulocyte-Macrophage Colony-Stimulating Factor
Humans
Humans
Immunotherapy
Immunotherapy
Lymphocyte Count
Lymphocyte Count
Male
Male
Middle Aged
Middle Aged
Neoplasm Staging
Neoplasm Staging
Pancreatic Neoplasms
Pancreatic Neoplasms
Prognosis
Prognosis
Radiotherapy Dosage
Radiotherapy Dosage
Retrospective Studies
Retrospective Studies
Survival Rate
Survival Rate

authors with profiles

Barish H Edil